Scientists in the laboratory of Rendong Yang, Ph.D., associate professor of Urology, have developed a new large language model that can interpret transcriptomic data in cancer cell lines more ...
On 4 February 2026, PharosAI announced it would use 10x Genomics’ Xenium spatial platform to convert archived NHS cancer ...
Atherosclerosis underlies most heart attacks and strokes and is now recognized as a chronic inflammatory disease rather than ...
The project focuses on increasing the diversity of genetic data and improving outcomes of conditions such as hypertension, diabetes, and triple-negative breast cancer.
N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a drug discovery company that is also investing in solar energy ...
SANTA CLARA, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- OmicInsight Corporation, an innovator in ...
A comprehensive single-cell atlas of AML uncovers regulatory networks and age-dependent molecular differences to advance the understanding of disease mechanisms and enable subtype-specific therapeutic ...
Atherosclerosis is driven not only by lipid accumulation but also by dynamic changes in the cells that form the vessel wall. This study reveals that ...
AZoLifeSciences on MSN
Proteomics approaches to overcome undruggable targets in disease
This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...
Interpretation is the discipline through which molecular datasets reveal their significance. As the life sciences enter a new era defined by data richness and technological capacity, interpretive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results